TNF and inflammatory bowel disease: By targeting various host immune molecules such as tumor necrosis factor (TNF), interleukins and adhesion molecules present on the surfaces of lymphocytes, biologics agents have revolutionized the medical management of inflammatory bowel disease (IBD).